Caffeic Acid Phenylethyl Amide Protects against the Metabolic Consequences in Diabetes Mellitus Induced by Diet and Streptozocin
Figure 3
Diet-induced hyperglycemia and hyperlipidemia were reduced by CAPA treatment in BLTW : CD1(ICR) mice. (a) Plasma glucose levels after 4 weeks of diet exposure. (b) Plasma insulin levels after 4 weeks of diet exposure. (c) Plasma triglycerides levels after 4 weeks of diet exposure. (d) Plasma total cholesterol levels after 4 weeks of diet exposure. 6–8 per group; means ± SEM; Con: control mice; HF: mice fed with high fat and diet; HFCA: HF mice treated with CAPA; HFMET: HF mice treated with metformin; *: versus Con; #: versus HF.
